Central African Republic vs Sudan: Immunization, Hib3
Central African Republic
42.0%
in 2024
Sudan
39.0%
in 2024
Central African Republic rank
188th
Sudan rank
191st
Immunization, Hib3 over time
- Central African Republic
- Sudan
How they compare
Central African Republic currently reports 42.0% against 39.0% in Sudan, a difference of 3.0%.
That makes Central African Republic's figure about 1.1 times Sudan's.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Sudan ahead.
Central African Republic ranks 188th and Sudan ranks 191st of 191 countries.
Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.0% | 72.0% | 30.0% | Sudan |
| 2010s | 41.2% | 91.4% | 50.2% | Sudan |
| 2020s | 37.4% | 69.4% | 32.0% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Central African Republic or Sudan?
- Central African Republic, at 42.0% against 39.0% in Sudan as of 2024.
- What is the difference in immunization, hib3 between Central African Republic and Sudan?
- 3.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Sudan?
- 16 years are reported by both, from 2009 to 2024.
- How do Central African Republic and Sudan rank globally for immunization, hib3?
- Central African Republic ranks 188th and Sudan ranks 191st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.